1H and 31P NMR lipidome of ethanol-induced fatty liver

Alcoholism: Clinical and Experimental Research

Volumn 34, Issue 11, 2010, Pages 1937-1947

  Fernando, Harshica ^a   Kondraganti, Shakuntala ^a   Bhopale, Kamlesh K ^a   Volk, David E ^a   Neerathilingam, Muniasamy ^a,b   Kaphalia, Bhupendra S ^a   Luxon, Bruce A ^a   Boor, Paul J ^a   Shakeel Ansari, G A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Ethanol; Fatty liver; Lipidomics; Lipids; Metabolomics

Indexed keywords

ALCOHOL; LIPIDOME; MALTODEXTRIN; PHOSPHOLIPID; TERT BUTYL METHYL ETHER; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CENTRAL DEPRESSANT AGENT; LIPID; PHOSPHORUS; PROTON;

ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CLUSTER ANALYSIS; CONTROLLED STUDY; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; LIVER; MALE; METABOLOME; MORPHOLOGY; MULTIVARIATE ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPECTROMETER; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; LIPID METABOLISM; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; STATISTICAL ANALYSIS; TOXIC HEPATITIS;

ANIMALIA; RATTUS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; DRUG-INDUCED LIVER INJURY; ETHANOL; FATTY LIVER, ALCOHOLIC; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIPIDS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; ORGAN SIZE; OXIDATIVE STRESS; PHOSPHORUS ISOTOPES; PRINCIPAL COMPONENT ANALYSIS; PROTONS; RATS; RATS, INBRED F344;

EID: 78049253514     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01283.x     Document Type: Article

References (73)

1. Akamatsu Y, Law JH (1970) The enzymatic synthesis of fatty acid methyl esters by carboxyl group alkylation. J Biol Chem 245:709-713.
2. Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK (2005) Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol 207:25-38.
3. Awl RA, Frankel EN, Weisleder D (1989) Synthesis and characterization of triacylglycerols containing linoleate and linolenate. Lipids 24:866-872.
4. Barak AJ, Beckenhauer HC, Tuma DJ, Badakhsh S (1987) Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem Cell Biol 65:230-233.
5. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692-2703.
6. Bhopale KK, Wu H, Boor PJ, Popov VL, Ansari GA, Kaphalia BS (2006) Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice. Alcohol 39:179-188.
7. Bradford BU, O'Connell TM, Han J, Kosyk O, Shymonyak S, Ross PK, Winnike J, Kono H, Rusyn I (2008) Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol 232:236-243.
8. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152.
9. Chapman D, Morrison A (1966) Physical studies of phospholipids. IV. High resolution nuclear magnetic resonance spectra of phospholipids and related substances. J Biol Chem 241:5044-5052.
10. Chung CH, Shugrue C, Nagar A, Doll JA, Cornwell M, Gattu A, Kolodecik T, Pandol SJ, Gorelick F (2009) Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator. Gastroenterology 136:331-340.
11. Crabb DW (1995) Ethanol oxidizing enzymes: roles in alcohol metabolism and alcoholic liver disease. Prog Liver Dis 13:151-172.
12. Crabb DW, Liangpunsakul S (2006) Alcohol and lipid metabolism. J Gastroenterol Hepatol 21(Suppl 3):S56-S60.
13. Day CP, James OF (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114:842-845.
14. Delgado-Villa MJ, Ojeda ML, Rubio JM, Murillo ML, Sanchez OC (2009) Beneficial role of dietary folic acid on cholesterol and bile acid metabolism in ethanol-fed rats. J Stud Alcohol Drugs 70:615-622.
15. DeLong CJ, Shen YJ, Thomas MJ, Cui Z (1999) Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J Biol Chem 274:29683-29688.
16. Diehl AM (2002) Liver disease in alcohol abusers: clinical perspective. Alcohol 27:7-11.
17. Feinman L, Lieber CS (1999) Ethanol and lipid metabolism. Am J Clin Nutr 70:791-792.
18. Griffin JL, Scott J, Nicholson JK (2007) The influence of pharmacogenetics on fatty liver disease in the Wistar and Kyoto rats: a combined transcriptomic and metabonomic study. J Proteome Res 6:54-61.
19. Gyamfi MA, Damjanov I, French S, Wan YJ (2008) The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem Pharmacol 75:981-995.
20. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med 5:1323-1327.
21. Harrigan GG, Maguire G, Boros L (2008) Metabolomics in alcohol research and drug development. Alcohol Res Health 31:26-35.
22. 31P NMR Spectroscopy. J Agric Food Chem 56:6232-6240.
23. Horning MG, Williams EA, Maling HM, Brodie BB (1960) Depot fat as source of increased liver triglycerides after ethanol. Biochem Biophys Res Commun 3:635-640.
24. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I (2003) Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38:123-132.
25. Israel-Jacard Y, Kalant H (1965) Effect of ethanol on electrolyte transport and electrogenesis in animal tissues. J Cell Physiol 65:127-132.
26. Jie MS, Cheng KL (1995) Nuclear magnetic resonance spectroscopic analysis of homoallylic and bis homoallylic substituted methyl fatty ester derivatives. Lipids 30:115-120.
27. Kaphalia BS, Carr JB, Ansari GA (1995) Increased endobiotic fatty acid methyl esters following exposure to methanol. Fundam Appl Toxicol 28:264-273.
28. Kaphalia BS, Green SM, Ansari GA (1999) Fatty acid ethyl and methyl ester synthases, and fatty acid anilide synthase in HepG2 and AR42J cells: interrelationships and inhibition by tri-o-tolyl phosphate. Toxicol Appl Pharmacol 159:134-141.
29. Kharbanda KK, Mailliard ME, Baldwin CR, Beckenhauer HC, Sorrell MF, Tuma DJ (2007) Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol 46:314-321.
30. Kim SJ, Jung YS, Kwon do Y, Kim YC (2008) Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation. Biochem Biophys Res Commun 368:893-898.
31. Knothe G (2007) Nuclear magnetic resonance spectroscopy, in The Lipid Handbook (Gunstone FD, Harwood JL, Dijkstra AJ eds), pp 455-459. CRC Press, Boca Raton.
32. Lieber CS, Cao Q, DeCarli LM, Leo MA, Mak KM, Ponomarenko A, Ren C, Wang X (2007) Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria. Alcohol Clin Exp Res 31:1660-1668.
33. Lieber CS, DeCarli LM (1989) Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol 24:197-211.
34. Lieber CS, Spritz N, DeCarli LM (1966) Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 45:51-62.
35. Lindon JC, Holmes E, Nicholson JK (2004) Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 6:265-272.
36. Lu SC, Huang ZZ, Yang H, Mato JM, Avila MA, Tsukamoto H (2000) Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol 279:G178-G185.
37. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49:1137-1146.
38. Van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9:112-124.
39. 31P NMR of extracted phospholipids. J Lipid Res 29:679-689.
40. Nakae D (1999) Endogenous liver carcinogenesis in the rat. Pathol Int 49:1028-1042.
41. Nanji AA (2004) Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34:21-25.
42. NIAAA (2000) 10th Special report to the U.S. Congress on Alcohol and Health. U.S. Department of Health and Human Services Research, Bethesda, MD.
43. 1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats. Chem Res Toxicol 21:408-420.
44. Ojeda ML, Delgado-Villa MJ, Llopis R, Murillo ML, Carreras O (2008) Lipid metabolism in ethanol-treated rat pups and adults: effects of folic acid. Alcohol Alcohol 43:544-550.
45. Oostendorp M, Engelke UFH, Willemsen MAAP, Wevers RA (2006) Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem 52:1395-1405.
46. 1H NMR spectroscopic studies of lipid extracts from human fatty liver. Biochem Biophys Res Commun 192:1217-1222.
47. Purohit V, Brenner DA (2006) Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 43:872-878.
48. Purohit V, Gao B, Song BJ (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33:191-205.
49. Purohit V, Khalsa J, Serrano J (2005) Mechanisms of alcohol-associated cancers: introduction and summary of the symposium. Alcohol 35:155-160.
50. Reid AE (2001) Nonalcoholic steatohepatitis. Gastroenterology 121:710-723.
51. Reo NV, Adinehzadeh M, Foy BD (2002) Kinetic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis using (13)C NMR spectroscopy. Biochim Biophys Acta 1580:171-188.
52. Ristic V, Vrbaski S, Lalic Z, Miric M (1995) The effect of ethanol and diazepam on the fatty acid composition of plasma and liver phospholipids in the rat. Biol Pharm Bull 18:842-845.
53. Roede JR, Orlicky DJ, Fisher AB, Petersen DR (2009) Overexpression of peroxiredoxin 6 does not prevent ethanol-mediated oxidative stress and may play a role in hepatic lipid accumulation. J Pharmacol Exp Ther 330:79-88.
54. Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, Roberts JP, Maher JJ, Niemann CU (2006) Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol 44:956-962.
55. Shi C, Wu CQ, Cao AM, Sheng HZ, Yan XZ, Liao MY (2007) NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats. Toxicol Lett 173:161-167.
56. 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors. NMR Biomed 22:663-674.
57. Sundler R, Akesson B (1975) Regulation of phospholipid biosynthesis in isolated rat hepatocytes. Effect of different substrates. J Biol Chem 250:3359-3367.
58. 1H Nmr. Biochim Biophys Acta 1054:198-206.
59. Tomita K, Tamiya G, Ando S, Kitamura N, Koizumi H, Kato S, Horie Y, Kaneko T, Azuma T, Nagata H, Ishii H, Hibi T (2005) AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin Exp Res 29:240S-245S.
60. Treinen-Moslen M(ed.) (2001) Toxic responses of the liver, in Casarett & Doull's Toxicology: The Basic Sciences of Poisons, 6th ed (Klassen CD ed.), pp 471-489. McGraw-Hill, New York.
61. 13C NMR lipid profiles of human renal tissues. Biopolymers 72:86-95.
62. Wainfan E, Kilkenny M, Dizik M (1988) Comparison of methyltransferase activities of pair-fed rats given adequate or methyl-deficient diets. Carcinogenesis 9:861-863.
63. Wei L, Liao PQ, Wu HF, Li XJ, Pei FK, Li WS, Wu YJ (2008) Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol Appl Pharmacol 227:417-429.
64. Wendt VE, Wu C, Balcon R, Doty G, Bing RJ (1965) Hemodynamic and metabolic effects of chronic alcoholism in man. Am J Cardiol 15:175-184.
65. Wilson WK, Sumpter RM, Warren JJ, Rogers PS, Ruan BF, Schroepfer GJ (1996) Analysis of unsaturated C-27 sterols by nuclear magnetic resonance spectroscopy. J Lipid Res 37:1529-1555.
66. Yao ZM, Vance DE (1988) The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 263:2998-3004.
67. Yao ZM, Vance DE (1990) Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem Cell Biol 68:552-558.
68. Yap IK, Clayton TA, Tang H, Everett JR, Hanton G, Provost JP, Le Net JL, Charuel C, Lindon JC, Nicholson JK (2006) An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J Proteome Res 5:2675-2684.
69. Yin HQ, Kim YC, Chung YS, Shin YK, Lee BH (2009) Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes. Toxicol Appl Pharmacol 236:124-130.
70. Yin HQ, Kim M, Kim JH, Kong G, Kang KS, Kim HL, Yoon BI, Lee MO, Lee BH (2007) Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol Appl Pharmacol 223:225-233.
71. You M, Crabb DW (2004) Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol 287:G1-G6.
72. You M, Fischer M, Deeg MA, Crabb DW (2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277:29342-29347.
73. Zatz M, Dudley PA, Kloog Y, Markey SP (1981) Nonpolar lipid methylation. Biosynthesis of fatty acid methyl esters by rat lung membranes using S-adenosylmethionine. J Biol Chem 256:10028-10032.